Clinical Group

International Journal of Immunotherapy and Cancer Research

ISSN: 2455-8591



About International Journal of Immunotherapy and Cancer Research

Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
  • Publication lead time3 - 4 weeks
  • Indexing statusYes; Purview
  • Manuscript Processing ChargesClick here
  • Submission ChargesNo
  • Waiver policy for APCYes
  • Language of Full TextEnglish
  • Full-text formats availablePDF, HTML
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
  • Does the author retain unrestricted copyright?Yes
  • Does the author retain publishing rights?Yes
  • Permanent article identifierDOI (Digital Object Identifier)


International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health

Read more

Editorial Board

Amir Avan
Assistant Professor
Department of modern Sciences & Technology
Mashhad University of Medical Science

Research Interest: Study of the mechanism of action, toxicity and efficacy of anticancer agents, as well as in the field of clinical pharmacology of chemotherapeutic drugs, including modeling of pharmacogenetic studies

Mohammad Zeeshan Najm
Associate Professor
Department of Biochemistry
Hamdard University

Research Interest: Molecular Biology/Cancer Biology

Constantinos Giaginis
Assistant Professor
Department of Food Science & Nutrition
University of Aegean

Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles

Steve A Maxwell
Associate Professor
Department of Molecular and Cellular Medicine
Texas A&M Health Science Center

Research Interest: Cancer Genetics, Apoptosis, Oncogenes, Tumor Suppressor Genes, Mechanisms of Anti-Cancer Drug Resistance.

Gabriele A Losa
Retired Professor
European Academy of Sciences

Research Interest: Cellular and Ultrastructural Biology, Tumor Morphometry and Enzymology, Fractals in Biology and Medicine, Apoptosis ,  Human Leukemia, Lymphocyte ultrastructure and metabolism.

Armando Varela
Department of Biological Sciences
University of Texas

Research Interest: Anti-Cancer, Apoptosis, Blebbing, Caspases, Cell Cycle, Cell Signaling, Cancer, DNA Fragmentation, Drug Discovery, Flow Cytometer, Intrinsic and extrinsic apoptosis pathway, Laser Confocal Microscope, Mitochondrial Depolarization and Necrosis.

David R. Minor
California Pacific Center for Melanoma Research and Treatment

Research Interest: Melanoma, kidney cancer , immunotherapy with ipilimumab, nivolumab, interleukin-2 and other agents. 

Tania Pencheva
Associate Professor
Department of QSAR and Molecular Modelling
Bulgarian Academy of Sciences

Research Interest:

• modelling, optimisation and control of biotechnological processes; 

• drug design, molecular modelling, virtual ligand screening; 

• metaheuristic algorithms; 

• intuitionistic fuzzy logic;

• generalised nets;

• intercriteria analysis in decision making systems

D Sugapriya
Assistant Professor
Department of Medical Lab Sciences
Prince Sattam Bin Abdullaziz University
Saudi Arabia

Research Interest: Immunophenotyping, Immunocytochemistry, Multilineag differentiation, RNA isolation, RT- PCR, Cancer cell line, Immunocytochemistry, Real-Time PCR, Western blot, Transport mechanism by liquid santillation Counter, Induction of leukemia in experimental animal, Biochemical enzymatic analysis, TEM analysis, Histopathology, RT-PCR, apoptosis analysis, Western blot, MTT assay, Measurement of intracellular ROS, Analysis of mitochondrial membrane potential, Intracellular calcium levels, Quantification of endogenous GSH, DNA fragmentation, Column Chromatography, Antibiotic sensitivity assay, Extract preparation, Antibiotic sensitivity assay

Raj Kumar Koiri
Assistant Professor
Department of Zoology
Dr. Hari Singh Gour Central University

Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

Birendra Kumar Yadav
Doctor of Philosophy
Rajiv Gandhi Cancer Institute & Research Center

Research Interest: signaling pathways, molecular studies and biosensor development for detection of cancer with the collaboration of nanotechnology experts.

Maurizio Chiriva Internati
Associate Professor
Department of Internal Medicine
University Texas Health Sciences Center

Research Interest: These cancers express unique tumor-specific or -associated antigens to which my lab directs T cell immune responses via DNA, RNA, protein or peptide based vaccines.  Vaccine components are delivered in their native form, by dendritic cells, by recombinant Adeno Associated Virus.  This clinically translational research is backed up by pre-clinical and basic research in both normal and transgenic animal models and in laboratory studies on patient material. Results from the pre-clinical studies have led to a variety of clinical trials for which I am the immunological coordinator. 

Amedeo Amedei
Associate Professor
Department of Experimental and Clinical Medicine
University of Florence, Firenze

Research Interest: Immunology, Cancer, ImmunoTherapy, Autoimmunity

Varun Kapoor
Genentech Inc

Research Interest: Unctional, heterogeneit of stromal cells lymphoid organs during health and disease particularly cancer.

Ji-Liang Li
Cancer Immunology
Plymouth University

Research Interest: Tumour Microenvironment and Translational Cancer Medicine

 Combination of cancer target therapy and immunotherapy

 Tumour associated macrophages

 Notch signalling in cancer biology

 Tumour resistance to target therapy and immunotherapy

 Hypoxia and angiogenesis pathways in cancer biology

 MicroRNAs in cancer target therapy and immunotherapy

 Experimental mouse tumour models

View more

Recent Articles

A Synchronous Presentation of AITL with Adenocarcinoma of Lung

Published On: October 06, 2016 | Pages: 011 - 013

Author(s): Kanagaraja Karunakaran Parathan*
View Article DOI: 10.17352/2455-8591.000009

Cytokine Production and Human Cytomegalovirus Load in Allogeneic Hematopoietic Stem Cell Transplantation Outcome

Published On: June 17, 2016 | Pages: 003 - 010

Author(s): TA Silva**, JF Correia-Silva, RG Resende, MHNG Abreu, AL Teixeira, H Bittencourt, RS Gomez
View Article DOI: 10.17352/2455-8591.000008

Endothelial Progenitor Cells in Breast Cancer

Published On: January 23, 2016 | Pages: 001 - 002

Author(s): Monica C Botelho*, Helena Alves
View Article DOI: 10.17352/2455-8591.000007

Anti-VEGF Therapy Induces Proteinuria through Endothelial Disorganization Leading to Nephrin Decrease in Podocytes

Published On: October 28, 2015 | Pages: 021 - 028

Author(s): Marianne Terrasse*, Florence Jouan, Thibault Dolley-Hitze, Yannick Arlot-Bonnemains, Marc-Antoine Belaud-Rotureau, Nathalie Rioux-Leclercq, Nolwenn Lorcy, Cécile Vigneau
View Article DOI: 10.17352/2455-8591.000006

Probiotics and Bone Health: It takes GUTS to Improve Bone Density

Published On: October 13, 2015 | Pages: 018 - 022

Author(s): Rupesh K Srivastava*, Hamid Yousf, Geetanjali B Tomar
View Article DOI: 10.17352/2455-8591.000005

N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer

Published On: September 03, 2015 | Pages: 013 - 017

Author(s): Raj Kumar Koiri*, Aditi Mehrotra
View Article DOI: 10.17352/2455-8591.000004

SMART Drug Based Targeted Delivery: A New Paradigm for Nanomedicine Strategies

Published On: August 20, 2015 | Pages: 008 - 012

Author(s): Sugapriya Dhanasekaran*
View Article DOI: 10.17352/2455-8591.000003

Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?

Published On: August 14, 2015 | Pages: 004 - 007

Author(s): Romeo-Gabriel Mihaila*
View Article DOI: 10.17352/2455-8591.000002

Adiponectin Regulates the Development and Progression of MCA-Induced Sarcoma in Mice

Published On: August 05, 2015 | Pages: 001 - 003

Author(s): Rongxin Zhang*, Kai Zhang, Xi Wu, Zhihui Zhang, Shuyu Fu, Yurong Da, Mei Mei, Qi Zhang, Yan Li, Zhenyi Xue, Lijuan Zhang, Peng Zhao
View Article DOI: 10.17352/2455-8591.000001